🇺🇸 FDA
Company

Century

Century Therapeutics

IPSC biotech USA

Quick answer

Century is a biotech company (IPSC) headquartered in PHILADELPHIA, PA, USA with 8 tracked pipeline programs.

Pipeline (8)

project

Aspirin 75 mg daily

Intracerebral Haemorrhage

Phase 3 · small_molecule · active

1 trials project

Stromal-vascular fraction

Knee Osteoarthritis

Phase 2 · mab · active

1 trials project

X-22 Smoking Cessation Product

Smoking Cessation

Phase 2 · small_molecule · completed

1 trials project

CNTY-101

Systemic Lupus Erythematosus

Phase 1 · mab · active

1 trials project

CNTY-101

R/R CD19-Positive B-Cell Malignancies

Phase 1 · mab · terminated

1 trials project

Nicotine gum (C)

Tobacco Use

Phase 1 · small_molecule · completed

2 trials project

DAOSiN®/ Placebo & ProvokAmin® Ingestion

Histamine Intolerance

Unknown · other · completed

1 trials project

Early auto-mode

Diabetes Mellitus Type 1 Pre-Existing

Unknown · other · completed

1 trials

Patents (8)

patent

US 12274710

Compound for regulating body weight imbalance, composition thereof and applicati

Expires Mon Apr 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12269888

Artificial cell death polypeptide for chimeric antigen receptor and uses thereof

Expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12194049

Composition for treating carbapenem antibiotic-resistant Acinetobacter baumannii

Expires Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12084670

Regulating alkaloids

Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11883432

Chimeric antigen receptor system with adaptable receptor specificity

Expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11865155

Plant extract obtained from Morus plant leaves which has an IC50 value to inhibi

Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11667924

Increasing levels of nicotinic alkaloids in plants

Expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11661459

Artificial cell death polypeptide for chimeric antigen receptor and uses thereof

Expires Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time)